Pages that link to "Q33815920"
Jump to navigation
Jump to search
The following pages link to Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3. (Q33815920):
Displaying 33 items.
- Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccines (Q27013568) (← links)
- An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors (Q27469506) (← links)
- Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics (Q28141424) (← links)
- Adenovector-mediated hair cell regeneration is affected by promoter type. (Q30364969) (← links)
- The E4-6/7 protein functionally compensates for the loss of E1A expression in adenovirus infection (Q33806341) (← links)
- Vectors for gene therapy of cardiovascular disease (Q34027386) (← links)
- Potential applications of gene therapy in the patient with cancer (Q34030512) (← links)
- Production of first generation adenovirus vectors: a review (Q34085243) (← links)
- Adenoviruses as vaccine vectors (Q34353523) (← links)
- Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure (Q34978011) (← links)
- Optimization of the helper-dependent adenovirus system for production and potency in vivo (Q34996749) (← links)
- Current status of gene therapy for inherited lung diseases (Q35043830) (← links)
- Implications of the innate immune response to adenovirus and adenoviral vectors (Q35085363) (← links)
- Immune responses against adenoviral vectors and their transgene products: a review of strategies for evasion. (Q35749783) (← links)
- Adenoviral producer cells (Q37945217) (← links)
- Progress on adenovirus-vectored universal influenza vaccines (Q38421971) (← links)
- CCL21/IL21-armed oncolytic adenovirus enhances antitumor activity against TERT-positive tumor cells (Q38772336) (← links)
- Adenovirus vectors with the 100K gene deleted and their potential for multiple gene therapy applications (Q39603174) (← links)
- Role for the adenovirus IVa2 protein in packaging of viral DNA (Q39604759) (← links)
- Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes (Q39682511) (← links)
- Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization (Q39682554) (← links)
- Rapid construction of adenoviral vectors by lambda phage genetics (Q39683249) (← links)
- Serum-free transient protein production system based on adenoviral vector and PER.C6 technology: high yield and preserved bioactivity (Q39977061) (← links)
- Comparison of the E3 and L3 regions for arming oncolytic adenoviruses to achieve a high level of tumor-specific transgene expression (Q40081527) (← links)
- Development and characterization of novel empty adenovirus capsids and their impact on cellular gene expression (Q40173334) (← links)
- Coexpression of p21WAF1/CIP1 in adenovirus vector transfected human primary hepatocytes prevents apoptosis resulting in improved transgene expression (Q40655745) (← links)
- Development of an Ad7 cosmid system and generation of an Ad7deltaE1deltaE3HIV(MN) env/rev recombinant virus (Q40669254) (← links)
- A rapid and easy method for production and selection of recombinant adenovirus genomes (Q40763574) (← links)
- Molecular regulation and biological function of adenovirus early genes: the E4 ORFs (Q42663829) (← links)
- Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector (Q44198855) (← links)
- Adenoviruses with an RGD-4C modification of the fiber knob elicit a neutralizing antibody response but continue to allow enhanced gene delivery (Q45231506) (← links)
- Development of adenovirus serotype 35 as a gene transfer vector (Q45863407) (← links)
- Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer (Q47251747) (← links)